Roskamp Institute Alzheimer’s Research Validated by Independent Japanese Study

Share this postShare on Google+Share on LinkedInShare on FacebookTweet about this on TwitterEmail this to someone

The Roskamp Institute announced on December 14, 2007 that an independent Tokyo Medical University study validates its ongoing research into the Alzheimer’s Disease drug Nilvadipine which is in testing. The International Journal of Geriatric Psychiatry details the results of study that suggests that Nilvadipine can prevent in people with memory problems the onset of Alzheimer’s.

For more information about this study and the Roskamp Institute, please contact Sarah Bascom or Kristen Bridges at (850) 222-2140 or www.mullanalzheimer.com.